Stocks and Investing Stocks and Investing
Mon, July 26, 2021
Fri, July 23, 2021

Jayson Bedford Maintained (ABT) at Buy with Increased Target to $128 on, Jul 23rd, 2021


Published on 2024-10-27 17:18:41 - WOPRAI, Jayson Bedford
  Print publication without navigation


Jayson Bedford of Raymond James, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $116 to $128 on, Jul 23rd, 2021.

Jayson has made no other calls on ABT in the last 4 months.



There are 10 other peers that have a rating on ABT. Out of the 10 peers that are also analyzing ABT, 2 agree with Jayson's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold with Increased Target to $128 on, Tuesday, July 20th, 2021
  • James Mainwaring of "Atlantic Equities" Initiated at Hold and Held Target at $122 on, Thursday, April 15th, 2021


These are the ratings of the 8 analyists that currently disagree with Jayson


  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $130 on, Thursday, July 22nd, 2021
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $135 on, Wednesday, July 21st, 2021
  • Marie Thibault of "BTIG" Maintained at Strong Buy with Increased Target to $126 on, Tuesday, July 20th, 2021
  • Joshua Jennings of "TD Cowen" Maintained at Buy with Decreased Target to $125 on, Friday, June 4th, 2021
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $125 on, Wednesday, June 2nd, 2021
  • Travis Steed of "Barclays" Maintained at Buy with Decreased Target to $125 on, Wednesday, June 2nd, 2021
  • Matthew Taylor of "UBS" Maintained at Strong Buy with Decreased Target to $127 on, Tuesday, June 1st, 2021
  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $140 on, Wednesday, April 21st, 2021
Contributing Sources